|
EspAddText
EspRemoveText
|
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
Putting Patients First : Comments on Bill C 6 (Personal Information Protection and Electronic Documents Act) : Submission to the Senate Standing Committee on Social Affairs, Science and Technology
|
Parliamentary submission
|
2019
|
|
EspAddText
EspRemoveText
|
Listening to our Patient's Concerns : Comments on Bill C 54 (Personal Information Protection and Electronic Document Act) : Submission to the House of Commons Standing Committee on Industry
|
Parliamentary submission
|
2019
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
|
Parliamentary submission
|
2013
|
|
EspAddText
EspRemoveText
|
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
The Health risks and harms associated with the use of marijuana
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Amendments to PIPEDA, Bill S-4
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Bill C-17 An Act to amend the Food and Drugs Act
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Proposed amendments to the marihuana for medical purposes regulations
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
Tamper Resistance under the Controlled Drugs and Substances Act
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
|
Parliamentary submission
|
2015
|
|
EspAddText
EspRemoveText
|
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act
(Vanessa's Law)
|
Response to consultation
|
2015
|
|
EspAddText
EspRemoveText
|
CMA’s formal submission to the Federal External Panel on assisted dying
|
Parliamentary submission
|
2019
|